Merck & Co. Divests Nine Ophthalmology Brands to Japan’s Santen Pharmaceutical
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 6 (Table of Contents)
Published: 6 Jun-2014
DOI: 10.3833/pdr.v2014.i6.2037 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a deal worth at least US$600 M, Japan’s Santen Pharmaceutical has agreed to buy nine of Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS